These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5964547)

  • 41. [D-2, 2'-(ethylenediimino)-di-1-butanol therapy on pulmonary disease caused by "unclassified" mycobacteria (nonphotochromogen)].
    Baba M
    Kekkaku; 1965 Dec; 40(12):551-4. PubMed ID: 5886180
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
    Giorgis GE; Moschini MT; Bardessono F; Amelio M
    Minerva Med; 1981 Jun; 72(25):1581-6. PubMed ID: 6789249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
    Krüüner A; Pehme L; Ghebremichael S; Koivula T; Hoffner SE; Mikelsaar M
    Clin Infect Dis; 2002 Jul; 35(2):146-55. PubMed ID: 12087520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary disease caused by scotochromogenic Mycobacteria.
    Tandon MK
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():307-10. PubMed ID: 4468035
    [No Abstract]   [Full Text] [Related]  

  • 45. Multifocal osteomyelitis due to Mycobacterium szulgai in a patient with chronic lymphocytic leukemia.
    Meyer JJ; Gelman SS
    J Infect; 2008 Feb; 56(2):151-4. PubMed ID: 18199481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study on efficacy of regimens including streptomycin or ethambutol].
    Li Q; Xiao C; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):76-8. PubMed ID: 11263387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of routine therapeutic protocols used in Madagascar for the treatment of smear-positive pulmonary tuberculosis (preliminary results)].
    Boisier P; Rabarijaonal L; Rakotomanana F; Ratsitorahina M; Ratsirahonana O; Roux J; Auregan G
    Arch Inst Pasteur Madagascar; 1995; 62(1):72-6. PubMed ID: 8638984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mycobacterial infections in Sweden.
    Romanus V
    Scand J Infect Dis Suppl; 1995; 98():15-6. PubMed ID: 8867171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Atypical mycobacteria today].
    Schröder KH
    Offentl Gesundheitswes; 1983 Jan; 45(1):38-40. PubMed ID: 6219321
    [No Abstract]   [Full Text] [Related]  

  • 50. [The activity of ethambutol in comparisons of experimental tuberculosis in the mouse].
    Lucchesi M; Zubiani M; Rossi P; Termine A
    Ann Ist Carlo Forlanini; 1966; 26(1):54-60. PubMed ID: 5919239
    [No Abstract]   [Full Text] [Related]  

  • 51. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Characteristics of non-tuberculous Mycobacterium -- pathogens of diseases in man].
    Otten TF
    Probl Tuberk; 1994; (3):56-9. PubMed ID: 7937677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
    Payen MC; De Wit S; Clumeck N
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S142-51. PubMed ID: 9496599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Infections with atypical mycobacteria. Diagnosis and therapy].
    Hansen G; Calmeyer M
    Tidsskr Nor Laegeforen; 1981 May; 101(13):790-2. PubMed ID: 7268714
    [No Abstract]   [Full Text] [Related]  

  • 55. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
    Shaĭkhaev AIa; Naumov VN
    Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The in vitro effect of ethambutol on atypical mycobacteria].
    Goda K; Sakamoto T
    Kekkaku; 1965 May; 40(5):154-7. PubMed ID: 5853349
    [No Abstract]   [Full Text] [Related]  

  • 58. A step forward in the evidence-based treatment of opportunist mycobacteria.
    Ormerod P
    Thorax; 2001 Mar; 56(3):163. PubMed ID: 11182003
    [No Abstract]   [Full Text] [Related]  

  • 59. [Tuberculosis resembling skin disease caused by Mycobacterium marinum (so-called swimming pool granuloma)].
    Cramer HJ; Hottenrott G
    Dtsch Gesundheitsw; 1967 Apr; 22(15):702-5. PubMed ID: 5590972
    [No Abstract]   [Full Text] [Related]  

  • 60. [Successful drug therapy in mycobacteriosis despite immunosuppression].
    Heurlin N; Petrini B
    Lakartidningen; 1988 Aug; 85(35):2757. PubMed ID: 3419265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.